IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ascendis Pharma A/S Sponsored ADR

CUSIP: 004351P10 | 1 institutional holders

Quarters

Q1 2019Q4 2018
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2019

Texas Children's16,206
0.1% of portfolio›$1.9K
StyleTurnoverLocationFiled
Texas Children's
16,206$1.9K0.1%N/AN/AHouston, TX2019-05-14